Cargando…
Initial treatment strategy and clinical outcomes in Finnish MS patients: a propensity-matched study
BACKGROUND: The optimal treatment strategy with disease-modifying therapies (DMTs) in relapsing–remitting multiple sclerosis (RRMS) remains uncertain. OBJECTIVE: To compare outcomes of initial treatment with infusion therapies and starting therapy with medium efficacy therapy in a propensity-matched...
Autores principales: | Hänninen, K., Viitala, M., Atula, S., Laakso, S. M., Kuusisto, H., Soilu-Hänninen, M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8782786/ https://www.ncbi.nlm.nih.gov/pubmed/34170403 http://dx.doi.org/10.1007/s00415-021-10673-9 |
Ejemplares similares
-
Real-world treatment outcomes and safety of natalizumab in Finnish multiple sclerosis patients
por: Verkkoniemi-Ahola, Auli, et al.
Publicado: (2023) -
Exposure to systemic antibiotics in outpatient care and the risk of multiple sclerosis
por: Sipilä, Jussi OT, et al.
Publicado: (2023) -
Medication adherence/persistence among patients with active multiple sclerosis in Finland
por: Lahdenperä, Sanni, et al.
Publicado: (2020) -
Comorbid epilepsy in Finnish patients with adult-onset Huntington’s disease
por: Sipilä, Jussi O. T., et al.
Publicado: (2016) -
Vitamin D supplementation and serum neurofilament light chain in interferon‐beta‐1b‐treated MS patients
por: Hänninen, Katariina, et al.
Publicado: (2020)